Clinical trial

Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients

NCT01271556

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhaseNA

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2011-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patientsunresolved

Chronic Obstructive Pulmonary Diseaseunresolved

Bronchodilator Agentsunresolved

Salmeterolunresolved

Interventions

SalmeterolDRUG · verified · RxNorm: salmeterol

saline infusion (0.9 per cent sodium chloride)PROCEDURE

Sponsors & collaborators

University of Milanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01271556 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.